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  Background
Cardiovascular disease is the main cause of mortality in the USA and Western countries, leading to a demand for new materials that 
can be used as substitutes for blood vessels. Bacterial cellulose (BC) is a material with excellent biocompatibility and mechanical 
properties, thus holding great potential for arterial replacement. To improve the adhesion of human microvascular endothelial cells 
(HMECs) to BC, chimeric proteins containing a cellulose-binding module (CBM) and an adhesion peptide (RGD or GRGDY) 
were produced and used to cover the cellulose fibers. The effects of these proteins were studied.
 Materials	&	methods
The attachment/viability and apoptosis were measured by the MTS and TUNEL methods, respectively. Confocal microscopy was 
used to analyze the morphology of microvascular cells grown on BC membrane. The visualization of cellulose fibers was also possible 
once the recombinant protein RGD-CBM was chemically linked to the fluorescein isothiocyanate. The formation of capillary-like 
structures by the endothelial cells was observed with optical microscopy. To evaluate the RGD effect on the migration of the cells 
through the BC, a migration chamber and an attractant were used to stimulate the cells to grow into the BC.
  Results
The results of the MTS test demonstrated that the recombinant proteins containing adhesion sequences were able to increase signifi-
cantly the attachment of HMEC to BC surfaces, and TUNEL assay showed that after 24 h of adhesion, independently of the treat-
ment, cells remained viable on the BC pellicle, even when less cells adhered to cellulose treated with the CBM or buffer comparing 
to RGD. The images by confocal microscopy showed that the cells on the BC treated with the RGD presented a more elongated 
morphology and proliferated on the pellicle, forming a confluent cell layer on the membrane after 7 days. The results showed that 
the RGD decreased the ingrowth of the HMEC cells through the BC and also stimulated the early assembly of endothelial cells into 
capillary-like structures.
  Conclusions
In this work, a new approach was successfully developed to functionalize the BC. The use of recombinant proteins containing a 
CBM domain, exhibiting high affinity and specificity for cellulose surfaces, allows the control on the interaction of this material 
with cells. The CBM may virtually be combined to any biologically active protein for the modification of cellulose-based materials, 
for in vitro or in vivo applications.
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 Objectives
Regenerative medicine increasingly requires accurate diagnostic techniques combined with cell-based therapies. However, cells sought 
for these applications are often rare in number and difficult to obtain/isolate, resulting in patients undergoing complicated, expensive 
and invasive procedures. These methods are time consuming with variable clinical success rates, largely due to poor or nonexistent 
cell-purification techniques.
The aim of this research was to develop a novel light-emitting photosensitive technique, based on patent US 7354733B2, capable 
of selecting targeted cells for diagnostics and eventual use in specific therapeutic applications.
